Lumigan Versus Cosopt

NCT00273455 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

34

Enrollment

OTHER

Sponsor class

Conditions

Open-Angle Glaucoma

Interventions

DRUG: bimatoprost 0.03%
DRUG: dorzolamide 2%/timolol maleate 0.5% fixed combination
DRUG: placebo

Sponsor

Pharmaceutical Research Network